Effects of uric acid on ischemic diseases, stratified by lipid levels: a drug-target, nonlinear Mendelian randomization study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Effects of uric acid on ischemic diseases, stratified by lipid levels: a drug-target, nonlinear Mendelian randomization study ; volume:14 ; number:1 ; day:16 ; month:1 ; year:2024 ; pages:1-7 ; date:12.2024
Scientific reports ; 14, Heft 1 (16.1.2024), 1-7, 12.2024
- Urheber
-
Kim, Jungeun
Lee, Sun Yeop
Lee, Jihye
Yoon, Sanghyuk
Kim, Eun Gyo
Lee, Eunbyeol
Kim, Nayoung
Lee, Sol
Gym, Ho
Park, Sang-In
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-51724-1
- URN
-
urn:nbn:de:101:1-2024032722205781845446
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kim, Jungeun
- Lee, Sun Yeop
- Lee, Jihye
- Yoon, Sanghyuk
- Kim, Eun Gyo
- Lee, Eunbyeol
- Kim, Nayoung
- Lee, Sol
- Gym, Ho
- Park, Sang-In
- SpringerLink (Online service)
Ähnliche Objekte (12)
Avoiding collider bias in Mendelian randomization when performing stratified analyses
Lipid-lowering drugs and inflammatory bowel disease’s risk: a drug-target Mendelian randomization study
Causality between serum uric acid and diabetic microvascular complications - a mendelian randomization study
New evidence: Metformin unsuitable as routine adjuvant for breast cancer: a drug-target mendelian randomization analysis
Assessing the safety of lipid-modifying medications among Chinese adolescents: a drug-target Mendelian randomization study
A Mendelian randomization study of serum uric acid with the risk of venous thromboembolism
Effects of genetically proxied lipid-lowering drugs on acute myocardial infarction: a drug-target mendelian randomization study
Uric acid and risk of gestational diabetes mellitus: an observational study and mendelian randomization analysis
Exploring the causal effect between lipid-modifying drugs and idiopathic pulmonary fibrosis: a drug-target Mendelian randomization study
Genetic proxies for therapy of insulin drug targets and risk of osteoarthritis: a drug-target Mendelian randomization analysis
Causal relationships between GLP1 receptor agonists, blood lipids, and heart failure: a drug-target mendelian randomization and mediation analysis
Investigating the causal association between serum uric acid levels and gastric cancer risk: a Mendelian randomization study
Avoiding collider bias in Mendelian randomization when performing stratified analyses
Lipid-lowering drugs and inflammatory bowel disease’s risk: a drug-target Mendelian randomization study
Causality between serum uric acid and diabetic microvascular complications - a mendelian randomization study
New evidence: Metformin unsuitable as routine adjuvant for breast cancer: a drug-target mendelian randomization analysis
Assessing the safety of lipid-modifying medications among Chinese adolescents: a drug-target Mendelian randomization study
A Mendelian randomization study of serum uric acid with the risk of venous thromboembolism
Effects of genetically proxied lipid-lowering drugs on acute myocardial infarction: a drug-target mendelian randomization study
Uric acid and risk of gestational diabetes mellitus: an observational study and mendelian randomization analysis
Exploring the causal effect between lipid-modifying drugs and idiopathic pulmonary fibrosis: a drug-target Mendelian randomization study
Genetic proxies for therapy of insulin drug targets and risk of osteoarthritis: a drug-target Mendelian randomization analysis
Causal relationships between GLP1 receptor agonists, blood lipids, and heart failure: a drug-target mendelian randomization and mediation analysis
Investigating the causal association between serum uric acid levels and gastric cancer risk: a Mendelian randomization study
Avoiding collider bias in Mendelian randomization when performing stratified analyses
Lipid-lowering drugs and inflammatory bowel disease’s risk: a drug-target Mendelian randomization study
Causality between serum uric acid and diabetic microvascular complications - a mendelian randomization study
New evidence: Metformin unsuitable as routine adjuvant for breast cancer: a drug-target mendelian randomization analysis
Assessing the safety of lipid-modifying medications among Chinese adolescents: a drug-target Mendelian randomization study
A Mendelian randomization study of serum uric acid with the risk of venous thromboembolism
Effects of genetically proxied lipid-lowering drugs on acute myocardial infarction: a drug-target mendelian randomization study
Uric acid and risk of gestational diabetes mellitus: an observational study and mendelian randomization analysis
Exploring the causal effect between lipid-modifying drugs and idiopathic pulmonary fibrosis: a drug-target Mendelian randomization study
Genetic proxies for therapy of insulin drug targets and risk of osteoarthritis: a drug-target Mendelian randomization analysis
Causal relationships between GLP1 receptor agonists, blood lipids, and heart failure: a drug-target mendelian randomization and mediation analysis